BICLUSTER_ID : DNREG-652
PATHOGENS /2/ : pseudomonas aeruginosa,helicobacter pylori
TARGETS /18/ : NDUFA6, RHOA, PIK3R1, NDUFA3, GMPS, NDUFS2, NDUFB6, MCM6, RAC1, NDUFB5, CTNNB1, NDUFB2, NDUFS1, NDUFA7, NDUFA2, SDHC, NDUFC1, NDUFA8
Gene SetLeading Edge Genes
REACTOME ELECTRON TRANSPORT CHAINNDUFA3, UQCRH, NDUFB5, NDUFS1, NDUFA7, CYC1, NDUFA2, SDHC, NDUFA8, NDUFA6, COX4I1, NDUFB6, NDUFS2, COX6A1, COX7C, UQCRC2, NDUFB2, NDUFC1
NCI ECADHERIN NASCENTAJ PATHWAYRAC1, RHOA, PIK3R1, CTNNB1, CTTN, CDC42, CRK, VAV2
BIOCARTA CDC42RAC PATHWAYARPC2, RAC1, RHOA, PIK3R1, CDC42, ACTR2
SOTIRIOU BREAST CANCER GRADE 1 VS 3 UPKIF20A, CDKN3, ESPL1, ORMDL2, LMNB1, CENPI, ZWINT, KIFC1, CENPA, TOP2A, PSMA7, UBE2N, CCNB2, GMPS, TPX2, NUDT1, PFDN6, CCT5, MCM6, NUP93, DNAJC9, RAD51, H2AFV, BIRC5
WANG RECURRENT LIVER CANCER UP
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP
BIOCARTA IGF1MTOR PATHWAY
MONTERO THYROID CANCER POOR SURVIVAL UPCCNB2, BIRC5, CENPA
MITSIADES RESPONSE TO APLIDIN DN
WHITEFORD PEDIATRIC CANCER MARKERSTWIST1, CCNB2, NUDT1, TPX2, POLE2, CENPA, H2AFX, TOP2A, MFN2, CENPF, BIRC5
KUMAMOTO RESPONSE TO NUTLIN 3A DN
NCI ARF6DOWNSTREAMPATHWAY
MANN RESPONSE TO AMIFOSTINE DN
NCI ECADHERIN KERATINOCYTE PATHWAY
REACTOME INSULIN SYNTHESIS AND SECRETION
DANG MYC TARGETS UP
ODONNELL TARGETS OF MYC AND TFRC DN
OSMAN BLADDER CANCER UP
WINNEPENNINCKX MELANOMA METASTASIS UP
NCI EPHA2 FWDPATHWAY
SCHLOSSER MYC TARGETS REPRESSED BY SERUM
LIU CMYB TARGETS DN
REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
CORUM CTBP COMPLEX
GINESTIER BREAST CANCER 20Q13 AMPLIFICATION UP
LUI THYROID CANCER CLUSTER 3
REACTOME METABOLISM OF PROTEINS
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx2 npgecpseudomonas aeruginosa fdr875helicobacter pylori kx1 npgecGeneSet Name
-0.00115 -0.19799 -0.00039REACTOME_ELECTRON_TRANSPORT_CHAIN
-0.01684 -0.15610 -0.00460NCI_ECADHERIN_NASCENTAJ_PATHWAY
-0.00627 -0.11352 -0.00320BIOCARTA_CDC42RAC_PATHWAY
-0.00042 -0.13049 -0.00041SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
-0.04592 -0.00391 -0.01680WANG_RECURRENT_LIVER_CANCER_UP
-0.01985 -0.16842 -0.02887RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
-0.17857 -0.00559 -0.05093BIOCARTA_IGF1MTOR_PATHWAY
-0.00121 -0.07018 -0.00349MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
-0.00683 -0.11107 -0.00925MITSIADES_RESPONSE_TO_APLIDIN_DN
-0.00648 -0.16651 -0.00303WHITEFORD_PEDIATRIC_CANCER_MARKERS
-0.04464 -0.18238 -0.08108KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.10829 -0.07125 -0.06754NCI_ARF6DOWNSTREAMPATHWAY
-0.15675 -0.10415 -0.05983MANN_RESPONSE_TO_AMIFOSTINE_DN
-0.01840 -0.00418 -0.00486NCI_ECADHERIN_KERATINOCYTE_PATHWAY
-0.19455 -0.00037 -0.16404REACTOME_INSULIN_SYNTHESIS_AND_SECRETION
-0.09591 -0.11241 -0.17659DANG_MYC_TARGETS_UP
-0.08707 -0.06053 -0.02871ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
-0.08575 -0.01987 -0.06399OSMAN_BLADDER_CANCER_UP
-0.00153 -0.05701 -0.00684WINNEPENNINCKX_MELANOMA_METASTASIS_UP
-0.08817 -0.08805 -0.02705NCI_EPHA2_FWDPATHWAY
-0.10600 -0.11106 -0.08176SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM
-0.16130 -0.09946 -0.02873LIU_CMYB_TARGETS_DN
-0.06882 -0.18698 -0.17878REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
-0.03355 -0.12954 -0.04675CORUM_CTBP_COMPLEX
-0.03061 -0.11986 -0.03446GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP
-0.03580 -0.13878 -0.11707LUI_THYROID_CANCER_CLUSTER_3
-0.10049 -0.19439 -0.09674REACTOME_METABOLISM_OF_PROTEINS